Orphanet: Simple search
x

Search for a diagnostic test

* (*) mandatory field

67 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

GERMANY

Sachsen
WEIßWASSER

Accreditation
Diagnosis of glioblastoma (EGFR and PPARG genes)
Praxis Dr. Mato Nagel
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

UNITED KINGDOM

Devon
EXETER

Accreditation
Molecular diagnosis of Non small-cell lung cancer response to Gefitinib/Erlotinib (EGFR TKD analysis: EGFR exons 18-21 by pyrosequencing/gene fragment analysis)
Royal Devon and Exeter Hospital - Wonford site
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation
Diagnosis of glioblastoma (EGFR gene)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Bayern
MARTINSRIED

Accreditation
Diagnosis of glioblastoma (EGFR gene)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Baden-Württemberg
FREIBURG

Accreditation
Diagnosis of glioblastoma (EGFR gene)
Synlab MVZ Freiburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Molecular analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques

GERMANY

Bayern
MARTINSRIED

Accreditation
Pharmacogenetic analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation
Diagnosis of glial tumor (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Sequence analysis: entire coding region, Detection of microdeletions/microduplications
Technique(s) : NGS sequencing (except WES), Sanger sequencing, FISH

GERMANY

Bayern
MÜNCHEN

Accreditation
Pharmacogenetic analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Pränatalmedizin München
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

AUSTRIA

OBERÖSTERREICH
LINZ

Accreditation
Molecular genetic and molecular cytogenetic analysis of EGFR, KRAS, ALK, and ROS1 for selection of therapeutic option in non-small cell lung carcinoma
Ordensklinikum Linz GmbH Barmherzige Schwestern
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Detection of chromosome alterations large in size
Technique(s) : Sanger sequencing, FISH

GERMANY

Niedersachsen
HANNOVER

Accreditation
Diagnosis of glioblastoma (EGFR gene)
amedes genetics im MVZ wagnerstibbe
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation
Diagnosis of inflammatory bowel disease (Panel)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

CANADA

Ontario
MISSISSAUGA

Accreditation
Molecular Analysis of EGFR in Non-Small Cell Lung Carcinoma (EGFR gene)
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Bayern
MÜNCHEN

Accreditation
Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Baden-Württemberg
ULM

Accreditation
Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Sachsen
DRESDEN

Accreditation
Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Bayern
WÜRZBURG

Accreditation
Diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation
Diagnosis of premature aging and laminopathies (Panel)
CHU de Marseille - Hôpital de la Timone
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Diagnosis of immunodeficiencies (NGS screening panel, 230 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Pharmacogenetic analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
Purpose(s) : Pharmacogenetics, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

GERMANY

Niedersachsen
HANNOVER

Accreditation
Molecular analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
amedes genetics im MVZ wagnerstibbe
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

BELGIUM

HAINAUT
GOSSELIES

Accreditation
Diagnosis of tubulopathies (gene panel)
Institut de Pathologie et de Génétique
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

BELGIUM

WEST-VLAANDEREN
BRUGGE

Accreditation
Diagnosis of solid tumors (panel of 22 genes)
AZ Sint-Jan Brugge
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Pathology
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

CANADA

Ontario
TORONTO

Accreditation
Molecular Diagnosis of Somatic Mutation of EGFR in Lung Adenocarcinoma (Exons 18,19,20,21, T790M)
Toronto General Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

CANADA

Ontario
TORONTO

Accreditation
Molecular Analysis of Non Squamous Non Small Cell Lung Cancer (EGFR analysis)
Toronto General Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, PCR based techniques

CANADA

Ontario
LONDON

Accreditation
Molecular Analysis of Tumor Tissue (Formalin Fixed Paraffin Embedded) EGFR, BRAF, KRAS/NRAS or COSMIC 2800 mutation panel
London Health Sciences Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

CANADA

Ontario
HAMILTON

Accreditation
Molecular Analysis of EGFR, KRAS, NRAS, BRAF for Solid Tumors (Formalin Fixed Paraffin Embedded Slides)
McMaster University Medical Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

UNITED KINGDOM

Surrey
SURREY

Molecular diagnosis of Glioblastoma (EGFR gene)
Institute of Cancer Research ICR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

SPAIN

Asturias
OVIEDO

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Hospital Universitario Central de Asturias
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
TERRASSA

Selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Consorci Sanitari de Terrassa
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

SPAIN

Andalucía
SEVILLA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Hospital Universitario Virgen del Rocío
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
TARRAGONA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Andalucía
MÁLAGA

Molecular diagnosis for selection of therapeutic option in non-small cell lung carcinoma (mutations in EGFR gene)
Hospital Regional Universitario de Málaga - Hospital General
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SPAIN

Asturias
OVIEDO

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Andalucía
GRANADA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (BRAF, EGFR, KRAS genes)
Máster Diagnóstica S. L.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

SPAIN

Comunidad Valenciana
PATERNA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
IMEGEN - Delegación Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

ITALY

BASILICATA
MATERA

Molecular diagnosis for selection of therapeutic option in non-small cell lung carcinoma (EGFR, ALK genes)
Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

LOMBARDIA
CREMONA

Selection of therapeutic option in non-small cell lung carcinoma (EGFR, KRAS genes)
Azienda Ospedaliera Istituti Ospitalieri di Cremona
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Other
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

ITALY

LOMBARDIA
MONZA

Selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
ASST Monza - Ospedale San Gerardo
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

SPAIN

Comunidad Valenciana
ELCHE

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Bioarray
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

SPAIN

Madrid
MADRID

Diagnosis of hereditary cancer (panel)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

La Rioja
LOGROÑO

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (BRAF, EGFR genes)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

La Rioja
LOGROÑO

Diagnosis of hereditary cancer (panel)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Cataluña
BARCELONA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (ALK, BRAF, EGFR, KRAS, MET, PIK3CA, ROS1, RET genes)
Hospital Universitari Dexeus - Grupo Quirónsalud
Purpose(s) : Pharmacogenetics, Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Detection of chromosome alterations large in size
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, FISH

SPAIN

Andalucía
MÁLAGA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Genologica
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

SPAIN

Comunidad Valenciana
VALENCIA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Fundación Instituto Valenciano de Oncología
Purpose(s) : Pharmacogenetics, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques

SPAIN

Galicia
A CORUÑA

Diagnosis of rare genetic immune disease (panel - 458 genes)
Health In Code
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

SPAIN

Galicia
A CORUÑA

Diagnosis of rare inflammatory bowel disease (panel - 26 genes)
Health In Code
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of cancer (panel)
Fundación Instituto Valenciano de Oncología
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

GERMANY

Hamburg
HAMBURG

Molecular analysis of EGFR gene for selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
UKE - Universitätsklinikum Hamburg-Eppendorf
Purpose(s) : Post-natal diagnosis, Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

SPAIN

Madrid
MADRID

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (gen EGFR)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Asturias
OVIEDO

Diagnosis of rare tumor (panel)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Navarra
PAMPLONA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (BRAF, EGFR, KRAS genes)
CIMA - Centro de Investigación Médica Aplicada
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Navarra
PAMPLONA

Diagnosis of solid tumors (panel)
CIMA - Centro de Investigación Médica Aplicada
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Andalucía
CÁDIZ

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Hospital Universitario Puerta del Mar
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of solid tumors (panel)
INCLIVA - Facultad de Medicina de la Universidad de Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Cataluña
BARCELONA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Hospital Universitari Vall d'Hebron
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

SPAIN

Castilla - León
PONFERRADA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (BRAF, EGFR, KRAS genes)
Ampligen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Madrid
MAJADAHONDA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (EGFR gene)
Instituto de Investigación Sanitaria Puerta de Hierro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

SPAIN

Comunidad Valenciana
VALENCIA

Analysis of the selection of therapeutic option in non-small cell lung carcinoma (BRAF, EGFR, KRAS genes)
Hospital General Universitario de Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of rare tumor (panel)
Seqplexing
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of selection of therapeutic option in non-small cell lung carcinoma (panel)
Fundación Hospital General Universitario de Valencia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

ITALY

PUGLIA
LECCE

Molecular diagnosis of predisposition to breast cancer (HER-2)
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

EMILIA ROMAGNA
BOLOGNA

Selection of therapeutic option in non-small cell lung carcinoma (EGFR, KRAS, ALK genes)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

AUSTRIA

TIROL
INNSBRUCK

Analysis for selection of therapeutic option in non-small cell lung carcinoma (EGFR, ALK, ROS1, RET, C-MET, HER-2)
Medizinische Universität Innsbruck
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Detection of chromosome alterations large in size
Technique(s) : Sanger sequencing, PCR based techniques, FISH